Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10096-023-04612-x.pdf
Reference6 articles.
1. Yetmar ZA, Khodadadi RB, Go JR, Chesdachai S, Abu Saleh OM (2023) Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 42:423–430
2. Online document. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.0_Breakpoint_Tables.pdf. Accessed 19 Mar 2023
3. Telles JP, Leme RCP, Campos ML, Ito C, Bail L, Nogueira KDS et al (2021) Ceftriaxone and methicillin-susceptible : a perspective from pharmacokinetics/pharmacodynamics studies. Expert Opin Drug Metab Toxicol 17:1039–1048
4. Zelenitsky SA, Beahm NP, Iacovides H, Ariano RE, Zhanel G (2018) Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis. J Antimicrob Chemother 1(73):1888–1894
5. Heffernan AJ, Sime FB, Lim SMS, Adiraju S, Wallis SC, Lipman J et al (2022) Pharmacodynamics of ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus: is it a viable treatment option? Int J Antimicrob Agents 59:106537
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3